Recurrent Ventricular Arrythmias in ICU
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Jun 13, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a serious heart condition called electrical storm, where dangerous irregular heartbeats happen repeatedly. These irregular beats can range from less severe types, which can be controlled with special heart treatments, to very severe ones that can cause life-threatening problems. The study aims to understand how often people survive long-term after being treated in the intensive care unit (ICU) for this condition, and what factors might affect their chances of survival.
The trial is open to all adults who have been admitted to the ICU with any type of dangerous irregular heartbeat related to this condition. While the study is not yet recruiting participants, those who qualify will have their health outcomes reviewed to help doctors learn more about the best ways to care for patients with electrical storm. This information could guide future treatments and improve survival for people facing this serious heart problem.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All ventricular arrythmias admitted in ICU -
- Exclusion Criteria:
- • -
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported